avapritinib
blueprint medicines
['ayvakit', 'blueprint medicine', 'blueprint medicines']
blueprint medicines slips as it changes endpoint for trial in aim to greatly broaden ayvakit label - more like this | #mastocytosis #eha2022 #ayvakit #healthcareconference #research #development #biotech 
Business intelligence for biotechs. We help #biotech innovators, investors, and business partners connect.